‘This cell therapy Parkinson’s program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.’ | Read More in JPost.com – Business & Innovation | The Jerusalem Post. in Israel NOWlej.
